Andrea Tubaro
Professore Ordinario
E-mail:
| Title | Published on | Year |
|---|---|---|
| Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4). A double-blind, multicentre, phase 3, randomised, placebo-controlled trial | THE LANCET ONCOLOGY | 2015 |
| The Current Indications and the Benefits of Combining a β3-Agonist with an Anticholinergic for the Treatment of OAB | CURRENT DRUG TARGETS | 2015 |
| Reply | UROLOGY | 2015 |
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma